Literature DB >> 15139499

Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.

Spilios Manolakopoulos1, Sotirios Bethanis, Anastasios Armonis, Michalis Economou, Alec Avgerinos, Dimitrios Tzourmakliotis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15139499     DOI： 10.1023/b:ddas.0000020504.41500.9c

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  22 in total

1.  Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid.

Authors:  B Kallinowski; L Theilmann; R Zimmermann; E Gams; B Kommerell; A Stiehl
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

2.  [Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study].

Authors:  L Salmon; J C Montet; C Oddoze; A M Montet; H Portugal; B F Michel
Journal:  Therapie       Date:  2001 Jan-Feb       Impact factor: 2.070

3.  Fulminant hepatitis due to cyproterone acetate.

Authors:  H Lévesque; C Trivalle; N D Manchon; J P Vinel; N Moore; J Hémet; H Courtois; E Bercoff; J Bourreille
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

Review 4.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

5.  Adverse effects of leuprolide acetate depot treatment.

Authors:  A J Friedman; M Juneau-Norcross; M S Rein
Journal:  Fertil Steril       Date:  1993-02       Impact factor: 7.329

Review 6.  Fatal fulminant hepatic failure due to cyproterone acetate.

Authors:  G Friedman; E Lamoureux; A H Sherker
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

7.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

8.  Fatal and nonfatal hepatotoxicity associated with flutamide.

Authors:  D K Wysowski; J P Freiman; J B Tourtelot; M L Horton
Journal:  Ann Intern Med       Date:  1993-06-01       Impact factor: 25.391

9.  Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.

Authors:  J L Gomez; A Dupont; L Cusan; M Tremblay; R Suburu; M Lemay; F Labrie
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965

10.  Fulminant hepatitis after flutamide treatment.

Authors:  S P Dourakis; A A Alexopoulou; S J Hadziyannis
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083
View more
  1 in total

Review 1.  Hepatotoxicity induced by cyproterone acetate: a report of three cases.

Authors:  Ioanna Savidou; Melanie Deutsch; Aspasia S Soultati; Dimitrios Koudouras; Georgia Kafiri; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.